Toxic gain function
Down Syndrome
Genotype
DYRK1A
Mechanism
Toxic gain function
Phenotype
Cognitive impairment, Hyperactivity, Anxiety, Social isolation, Sleep disorder, Motor coordination, Compulsive behaviors
Biomarker
Total tau, BDNF, NfL, S100B
Gene Expression Markers
SOD1, APP, SYN1, PSD95, GAP43, CAT, BCL2
Physiology Changes
Reduced body size and brain volume, Hypotonia, Jaw dysmorphism, EEG - Spike-and-wave discharges, Slowing of EEG rhythms, Reduced REM sleep
Histology Grading Endpoint
Reduced neuronal density, Reduced dendritic spine density, Increased astrocyte activation, Amyloid plaques and Neurofibrillary tangles



